Publications by authors named "Fuhao Xu"

Claim this Profile
S
Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer.
Hengrui Liang, Wei Wang, Man Zhang, Runchen Wang, Shunjun Jiang, Fuhao Xu

Ann Thorac Surg· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional Patterning Super-Black Silica-Based Nanocomposite Aerogels.
Zhiyang Zhao, Romain Civioc, Wei Liu, Peiying Hu, Mengmeng Li, Fuhao Xu

Nanomicro Lett· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantum Oncology: The Applications of Quantum Computing in Cancer Research.
Jiaran Li, Li Li, Ning Liu, Fuhao Xu, Tao Hu

J Med Syst· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of neoadjuvant chemotherapy plus immunotherapy versus chemoradiotherapy for esophageal squamous cell carcinoma patients: efficacy and safety outcomes.
Shuming Shi, Li Li, Hao Zhou, Fuhao Xu, Ning Liu

J Thorac Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of the value of indocyanine green fluorescence imaging in guiding surgical resection of primary and metastatic liver cancer.
Dali Xiong, Jiaran Li, Li Li, Fuhao Xu, Tao Hu, Xiaohui Xu

Photodiagnosis Photodyn Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biomarker exploration in small-cell lung cancer for brain metastases risk and prophylactic cranial irradiation therapy efficacy.
Li Li, Ning Liu, Tao Zhou, Xueting Qin, Xiaoyu Song, Fuhao Xu

Lung Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Volume Constraints Parameters for Lung Tissue in Thoracic Radiotherapy Following Immune Checkpoint Inhibitor Treatment.
Kang Wang, Fengchang Yang, Changxing Feng, Fuhao Xu, Li Li

J Inflamm Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study.
Shuming Shi, Hao Zhou, Li Li, Fuhao Xu, Ning Liu, Xiaohui Xu

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic biomarker tumor-infiltrating lymphocytes failed to serve as a predictive biomarker for postoperative radiotherapy in completely resected pN2 non-small cell lung cancer: a retrospective analysis.
Jiaran Li, Li Li, Jingjing Wang, Ning Liu, Haixin Liu, Fuhao Xu

Respir Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatiotemporal distribution of mediastinal neoplasms: A comprehensive multi-center study.
Yu Jiang, Yuechun Lin, Chao Yang, Ping He, Zhichao Liu, Haixuan Wang, Fuhao Xu, Xu Lin, Xin Xu, Xuefeng Leng

Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: A retrospective study.
Fuhao Xu, He Zhu, Dali Xiong, Kang Wang, Yinjun Dong

Thorac Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
Fuhao Xu, He Zhu, Yinjun Dong, Li Li, Ning Liu

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis